Europe 1 with AFP 5:05 p.m., September 20, 2022

The High Authority for Health gave the green light on Tuesday to the three anti-Covid vaccines, two developed by Pfizer / BioNTech and one by Moderna, adapted to the Omicron variant.

The High Health Authority gives the green light to three anti-Covid vaccines adapted to Omicron for a new booster vaccination campaign planned for the fall and coupled with that against the flu, it announced on Tuesday in a press release.

This new booster dose will be recommended to people at risk of a severe form, to those around them and to caregivers.

The HAS recommends "indifferently one of the three bivalent vaccines" - two developed by Pfizer / BioNTech, the third by Moderna - recently validated by the European Medicines Agency.

>> More information to follow...